| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |